SHPH

SHPH

USD

Shuttle Pharmaceuticals Holdings Inc. Common Stock

$2.500+0.020 (0.806%)

实时价格

Healthcare
Drug Manufacturers - Specialty & Generic
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$2.480

最高价

$2.509

最低价

$2.245

成交量

0.08M

公司基本面

市值

2.7M

所属行业

Drug Manufacturers - Specialty & Generic

国家/地区

United States

交易统计

平均成交量

0.22M

交易所

NCM

货币

USD

52周价格范围

最低价 $2.2455当前价 $2.500最高价 $30.825

相关新闻

AccessWire

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Every generation has its frontier. For the last century, medicine's remained molecular: genes, proteins, receptors, the invisible mechanics of life. Today, that

查看更多
Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)
AccessWire

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Artificial intelligence has reshaped nearly every industry, but drug discovery has always been its toughest proving ground. Molecules don't follow patterns; they

查看更多
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)
AccessWire

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

ROCKVILLE, MD / ACCESS Newswire / October 21, 2025 / Radiation therapy has always been the heavyweight of cancer treatment. It works, but it's a brute. It blasts cancer cells, hoping the good ones can withstand the

查看更多
Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)
GlobeNewswire

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company, today

查看更多
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market